Literature DB >> 22325453

Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans.

Gijs H Goossens1, Ellen E Blaak, Ruud Theunissen, Adriaan M Duijvestijn, Karine Clément, Jan-Willem Cohen Tervaert, Marielle M Thewissen.   

Abstract

Recent studies in rodents indicate that the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome and a proinflammatory shift in the T cell population in adipose tissue (AT) contribute to AT inflammation and insulin resistance. We investigated: (1) the interplay between the NLRP3 inflammasome and T cell populations in abdominal subcutaneous AT in obese and lean humans in relation to AT inflammatory processes, and (2) involvement of the NLRP3 inflammasome and T cell populations in insulin resistance. Abdominal subcutaneous AT biopsies were collected in 10 obese men with impaired glucose tolerance and 9 lean normal glucose tolerant age-matched controls. AT gene expression of NLRP3 inflammasome-related genes and markers of T cell populations, chemoattraction, macrophage infiltration and other aspects of inflammation were examined. Furthermore, we examined systemic adaptive immune activation and insulin sensitivity (hyperinsulinemic-euglycemic clamp). CASPASE-1 mRNA and the proportion of T(h)1 transcripts (TBX21/CD3ɛ) were significantly higher in AT from obese compared with lean subjects. CASPASE-1 expression and a relative increase in T(h)1 transcripts in AT were strongly associated with insulin resistance and impairments in glucose homeostasis. Gene expression of NLRP3, CASPASE-1, CD3ɛ (pan T cells), TBX21 (T(h)1 cells) and RORC (T(h)17 cells) was positively, whereas GATA3 (T(h)2 cells) was inversely correlated with AT inflammation. Our data suggest that NLRP3 inflammasome activation and a T(h)1 shift in the T cell population in AT of obese subjects is related to insulin resistance and impaired glucose metabolism, which may be explained by AT inflammatory processes. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22325453     DOI: 10.1016/j.molimm.2012.01.005

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  43 in total

Review 1.  Novel Mediators of Adipose Tissue and Muscle Crosstalk.

Authors:  Ira Indrakusuma; Henrike Sell; Jürgen Eckel
Journal:  Curr Obes Rep       Date:  2015-12

2.  Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects.

Authors:  Javier Traba; Miriam Kwarteng-Siaw; Tracy C Okoli; Jessica Li; Rebecca D Huffstutler; Amanda Bray; Myron A Waclawiw; Kim Han; Martin Pelletier; Anthony A Sauve; Richard M Siegel; Michael N Sack
Journal:  J Clin Invest       Date:  2015-11-03       Impact factor: 14.808

Review 3.  Inflammasomes and metabolic disorders: old genes in modern diseases.

Authors:  Gregory R Robbins; Haitao Wen; Jenny P-Y Ting
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

Review 4.  Mitochondrial fidelity and metabolic agility control immune cell fate and function.

Authors:  Michael N Sack
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

5.  RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance.

Authors:  Pedro M Moraes-Vieira; Mark M Yore; Peter M Dwyer; Ismail Syed; Pratik Aryal; Barbara B Kahn
Journal:  Cell Metab       Date:  2014-03-04       Impact factor: 27.287

Review 6.  The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications--a review.

Authors:  Antonio Macciò; Clelia Madeddu
Journal:  J Mol Med (Berl)       Date:  2013-09-21       Impact factor: 4.599

7.  Subcutaneous fat transplantation alleviates diet-induced glucose intolerance and inflammation in mice.

Authors:  Samantha L Hocking; Rebecca L Stewart; Amanda E Brandon; Eurwin Suryana; Ella Stuart; Emily M Baldwin; Ganesh A Kolumam; Zora Modrusan; Jagath R Junutula; Jenny E Gunton; Michael Medynskyj; Sinead P Blaber; Elisabeth Karsten; Benjamin R Herbert; David E James; Gregory J Cooney; Michael M Swarbrick
Journal:  Diabetologia       Date:  2015-04-22       Impact factor: 10.122

Review 8.  The role of caloric load and mitochondrial homeostasis in the regulation of the NLRP3 inflammasome.

Authors:  Javier Traba; Michael N Sack
Journal:  Cell Mol Life Sci       Date:  2016-12-10       Impact factor: 9.261

Review 9.  The outliers become a stampede as immunometabolism reaches a tipping point.

Authors:  Barbara S Nikolajczyk; Madhumita Jagannathan-Bogdan; Gerald V Denis
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

10.  B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile.

Authors:  Jason DeFuria; Anna C Belkina; Madhumita Jagannathan-Bogdan; Jennifer Snyder-Cappione; Jordan David Carr; Yanina R Nersesova; Douglas Markham; Katherine J Strissel; Amanda A Watkins; Min Zhu; Jessica Allen; Jacqueline Bouchard; Gianluca Toraldo; Ravi Jasuja; Martin S Obin; Marie E McDonnell; Caroline Apovian; Gerald V Denis; Barbara S Nikolajczyk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.